CoChat

Effects of exendin‐4 on islets from type 2 diabetes patients

Lupi, R., Mancarella, R., Del Guerra, S., Bugliani, M., Del Prato, S., Boggi, U., Mosca, F., Filipponi, F., Marchetti, P. · 2008 · Diabetes, Obesity and Metabolism
Cited by 47

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Exendin‐4 is a dipeptidyl peptidase IV (DPP‐IV)‐resistant glucagon‐like peptide1 (GLP‐1) mimetic and its synthetic counterpart, exenatide, is being used in the therapy of type 2 diabetes (T2DM). No information, however, is currently available as for the direct action of exendin‐4 on human T2DM islets. In the present study, we exposed pancreatic islets prepared from non‐diabetic and T2DM subjects to exendin‐4 for 48 h and found that the compound had several, direct beneficial actions on insulin secretion and the expression of genes involved in beta‐cell function and differentiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1463-1326.2007.00838.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 47

Metadata

Authors
Lupi, R., Mancarella, R., Del Guerra, S., Bugliani, M., Del Prato, S., Boggi, U., Mosca, F., Filipponi, F., & Marchetti, P.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2008-01-14
Volume
10
Issue
6
Pages
515-519
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2108962109
Cited by
47
References
5
FWCI
6.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of exendin‐4 on islets from type 2 diabetes patients. https://app.cochat.ai/papers/10.1111/j.1463-1326.2007.00838.x
The paper
Lupi, R., Mancarella, R., Del Guerra, S., Bugliani, M., Del Prato, S., Boggi, U., Mosca, F., Filipponi, F., & Marchetti, P. (2008). Effects of exendin‐4 on islets from type 2 diabetes patients. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2007.00838.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.